Current Affairs - National - Discussion

Discussion :: National - Latest Current Affairs (Q.No.873)

873. 

Which institute has started the trial of Mycobacterium w (Mw), an anti-leprosy drug on COVID-19 patients?

[A]. The Indian Institute of Technology
[B]. Council of Scientific and Industrial Research
[C]. Indian Council of Medical Research
[D]. All India Institute of Medical Sciences

Answer: Option B

Explanation:

The Council of Scientific and Industrial Research (CSIR) has started the trial of Mycobacterium w (Mw), an anti-leprosy drug. The information was passed by the Director of CSIR Shekhar Mande. Under this one particular formulation, called "Mycobacterium w (Mw)", a heat-killed bacteria will be tried on different COVID-19 patients. CSIR has been granted approval to conduct the trial from the Drug Controller General of India (DCGI).

Post your comments here:

Name *:

Email   : (optional)

» Your comments will be displayed only after manual approval.